A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
Weizhi Wang, Chao Liu, Jinque Luo, Li-juan Lei, Minghua Chen, Yuyan Zhang, Ren Sheng, Yining Li, Li Wang, Xin-hai Jiang, Tong-mei Xiao, Yuhao Zhang, S. Li, Yexiang Wu, Xu Yang, Yanni Xu, Shuyi Si
Topics & Concepts
PCSK9LDL receptorHyperlipidemiaKexinInternal medicineEndocrinologyCholesterolTriglycerideLipoproteinApolipoprotein BChemistryFamilial hypercholesterolemiaProprotein convertaseBiologyMedicineDiabetes mellitusLipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesSystemic Lupus Erythematosus Research